New combo pill shows promise for diabetes control in japanese patients
NCT ID NCT02354235
First seen Jan 09, 2026 · Last updated Jun 13, 2026 · Updated 24 times
Summary
This study tested a combination of two diabetes medications, teneligliptin and canagliflozin, taken once daily for 24 weeks. It included 138 Japanese adults with type 2 diabetes whose blood sugar was not well controlled on teneligliptin alone. The goal was to see if adding canagliflozin improved blood sugar levels and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Reserch site
Kanto, Japan
-
Reserch site
Kinki, Japan
-
Reserch site
Tōhoku, Japan
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.